Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-09-24Clinical Trial Update: Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation [Phase 3]
Phase 3 trial evaluating immunization of sibling bone marrow donors against the recipient's purified myeloma protein undergoing allogeneic b…
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. [Phase 3]
Phase 3 trial evaluating adjuvant intravenous iron therapy during erythropoietin treatment for anemia in patients with lymphoproliferative d…
-
CLINICAL_TRIALS trial_result · 2007-04-24Clinical Trial Update: Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. [Phase 1]
Phase 1 safety trial evaluating parathyroid hormone for stem cell mobilization in patients with lymphoma, multiple myeloma, or acute myeloid…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood [Phase 2]
This is a Phase 2 trial update evaluating low-intensity conditioning and immunotherapy for high-risk blood cancers; the study has been termi…
-
CLINICAL_TRIALS trial_result · 2007-02-14Clinical Trial Update: A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
A clinical trial update examines two strategies for combining dexamethasone with Velcade (bortezomib) to treat multiple myeloma; the study i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-01-04Clinical Trial Update: Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month [Phase 3]
A Phase 3 trial comparing 30 mg/month versus 90 mg/month pamidronate prophylaxis in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-20Clinical Trial Update: Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma. [Phase 2]
Phase 2 trial evaluating simvastatin as an inhibitor of cell adhesion–mediated drug resistance in patients with refractory multiple myeloma;…
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients [Phase 2]
Phase 2 clinical trial evaluating a combination of melphalan, prednisone, thalidomide, and bortezomib in advanced and refractory multiple my…
-
CLINICAL_TRIALS trial_result · 2006-11-30Clinical Trial Update: Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update summarizes completion of Phase 1 and Phase 2 investigation of induction therapy with melphalan, prednisone, and C…
-
CLINICAL_TRIALS trial_result · 2006-11-17Clinical Trial Update: ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells [Phase 1]
Phase 1 trial evaluating mobilization of hematopoietic stem and progenitor cells using all-trans retinoic acid (ATRA) in combination with G-…
-
CLINICAL_TRIALS trial_result · 2006-11-09Clinical Trial Update: Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [Phase 3]
A Phase 3 trial by Pfizer evaluated the safety and efficacy of PN-152,243 and PN-196,444 to prevent thrombocytopenia in cancer patients; the…
-
CLINICAL_TRIALS trial_result · 2006-10-13Clinical Trial Update: A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. [Phase 2, Phase 3]
The document provides an update on a randomized trial comparing somatropin (human growth hormone) to placebo in intensively treated hematolo…
-
CLINICAL_TRIALS trial_result · 2006-10-11Clinical Trial Update: Atorvastatin in Myeloma [Phase 1]
Phase 1 trial update evaluating atorvastatin for Multiple myeloma; no results or current status are provided.
-
CLINICAL_TRIALS trial_result · 2006-09-19Clinical Trial Update: Autologous Transplantation for Multiple Myeloma [Phase 3]
This Phase 3 clinical trial update reports results of autologous transplantation in patients with Multiple Myeloma conducted by the Universi…
-
CLINICAL_TRIALS trial_result · 2006-08-22Clinical Trial Update: Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma [Phase 3]
Clinical trial update for a Phase 3 study in newly diagnosed elderly patients with multiple myeloma has completed. No specific results are p…
-
CLINICAL_TRIALS trial_result · 2006-06-16Clinical Trial Update: Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating Velcade (bortezomib) plus high-dose dexamethasone in newly diagnosed multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-06-08Clinical Trial Update: A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma [Phase 2]
A completed Phase 2 clinical trial evaluating Motexafin Gadolinium (Xcytrin) for relapsed or refractory multiple myeloma, sponsored by Pharm…
-
CLINICAL_TRIALS trial_result · 2006-05-09Clinical Trial Update: A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma [Phase 2]
A Phase II trial comparing quality of life, tolerability and toxicity of PEG Intron versus INTRON A in patients with Multiple Myeloma has co…